Ochsner, Scott A.
Abraham, David
Martin, Kirt
Ding, Wei
McOwiti, Apollo
Kankanamge, Wasula
Wang, Zichen http://orcid.org/0000-0002-1415-1286
Andreano, Kaitlyn
Hamilton, Ross A.
Chen, Yue
Hamilton, Angelica
Gantner, Marin L.
Dehart, Michael
Qu, Shijing
Hilsenbeck, Susan G.
Becnel, Lauren B.
Bridges, Dave
Ma’ayan, Avi http://orcid.org/0000-0002-6904-1017
Huss, Janice M.
Stossi, Fabio
Foulds, Charles E.
Kralli, Anastasia
McDonnell, Donald P.
McKenna, Neil J. http://orcid.org/0000-0001-6689-0104
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (DK107535, DK115900, DK105126, DK48807)
Cancer Prevention and Research Institute of Texas (RP150578)
Article History
Received: 22 February 2019
Accepted: 11 September 2019
First Online: 31 October 2019
Competing interests
: Charles Foulds has equity in Coactigon, Inc.